ViaDerma Inc (VDRM)

[Beninvest]

Thank you for your opinion.

Here’s an old PR- second paragraph is my response to “no inventory”. No idea what will be on the quarterly but it’s something to talk about. Instead of just bashing people…

LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices. The medical practices provide advanced wound care treatment to homebound patients and are currently operating in six states. ViaDerma’s goal is to increase its presence to medical practices in sixteen states this year and to be in all fifty states by the end of 2022.

As part of their wound care treatment protocol, the medical practices will be utilizing their own private label medication based on the technology developed by ViaDerma President and CEO, Dr. Chris Otiko.